| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Urogen Pharma Ltd. (URGN) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. URGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 153.2K | $5.36M | - | |
| Other | 55.6K | $1.95M | - | |
| Dir | 20.0K | $699.8K | - | |
| CFO | 2.3K | $79.8K | - | |
| Dir | 2.0K | $70.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | Barrett Elizabeth A. | Chief Executive Officer | Sale+OE | 46,968 | $9.15 | $429,757.20 | -13.6% | -5.4% | -3.1% | |
| Nov 30, 2021 | Smith Jason Drew47 | General Counsel | Sale+OE | 3,803 | $12.03 | $45,750.09 | -35.1% | -50.4% | -29.1% | |
| Nov 30, 2021 | Henderson Molly52 | Chief Financial Officer | Sale+OE | 2,587 | $12.03 | $31,121.61 | -34.5% | -50.4% | -29.1% | |
| Nov 18, 2021 | Schoenberg Mark60 | Chief Medical Officer | Buy | 160 | $13.10 | $2,096.00 | +0.7% | -44.7% | -33.0% | |
| Nov 1, 2021 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 258 | $17.16 | $4,427.28 | -1.2% | -54.6% | -31.1% | |
| Oct 27, 2021 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 107 | $16.32 | $1,746.24 | -0.5% | -50.8% | -28.3% | |
| Aug 2, 2021 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 243 | $15.64 | $3,800.52 | -1.1% | +8.9% | -51.9% | |
| Jul 26, 2021 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 103 | $15.30 | $1,575.90 | -0.5% | +7.8% | -47.4% | |
| May 17, 2021 | Henderson Molly52 | Chief Financial Officer | Buy | 2,500 | $15.85 | $39,625.00 | New | -6.5% | -63.2% | |
| May 17, 2021 | Smith Jason Drew47 | General Counsel | Buy | 2,500 | $15.71 | $39,275.00 | New | -6.5% | -63.2% |